Literature DB >> 25818802

Collateral sensitivity of antibiotic-resistant microbes.

Csaba Pál1, Balázs Papp2, Viktória Lázár2.   

Abstract

Understanding how evolution of microbial resistance towards a given antibiotic influences susceptibility to other drugs is a challenge of profound importance. By combining laboratory evolution, genome sequencing, and functional analyses, recent works have charted the map of evolutionary trade-offs between antibiotics and have explored the underlying molecular mechanisms. Strikingly, mutations that caused multidrug resistance in bacteria simultaneously enhanced sensitivity to many other unrelated drugs (collateral sensitivity). Here, we explore how this emerging research sheds new light on resistance mechanisms and the way it could be exploited for the development of alternative antimicrobial strategies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antibiotic resistance; collateral sensitivity; cross-resistance; experimental evolution; multidrug resistance

Mesh:

Substances:

Year:  2015        PMID: 25818802      PMCID: PMC5958998          DOI: 10.1016/j.tim.2015.02.009

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  37 in total

1.  Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp.

Authors:  M Macvanin; U Johanson; M Ehrenberg; D Hughes
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

2.  The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Clara Davis Long; Peter M Small; Tran Van; Gary K Schoolnik; Brendan J M Bohannan
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

3.  Collateral damage.

Authors:  Robert E W Hancock
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

4.  Application of Traditional and Phylogenetically Based Comparative Methods to Test for a Trade-off in Bacterial Growth Rate at Low versus High Substrate Concentration.

Authors: 
Journal:  Microb Ecol       Date:  1999-10       Impact factor: 4.552

5.  Molecular analysis of fusidic acid resistance in Staphylococcus aureus.

Authors:  Silke Besier; Albrecht Ludwig; Volker Brade; Thomas A Wichelhaus
Journal:  Mol Microbiol       Date:  2003-01       Impact factor: 3.501

6.  Aminoglycoside uptake increased by tet gene expression.

Authors:  T L Merlin; G E Davis; W L Anderson; R K Moyzis; J K Griffith
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

7.  Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.

Authors:  Michele D Hastings; Carol Hopkins Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-27       Impact factor: 11.205

8.  Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.

Authors:  Mark A Webber; Vito Ricci; Rebekah Whitehead; Meha Patel; Maria Fookes; Alasdair Ivens; Laura J V Piddock
Journal:  mBio       Date:  2013-07-23       Impact factor: 7.867

9.  Bacterial evolution of antibiotic hypersensitivity.

Authors:  Viktória Lázár; Gajinder Pal Singh; Réka Spohn; István Nagy; Balázs Horváth; Mónika Hrtyan; Róbert Busa-Fekete; Balázs Bogos; Orsolya Méhi; Bálint Csörgő; György Pósfai; Gergely Fekete; Balázs Szappanos; Balázs Kégl; Balázs Papp; Csaba Pál
Journal:  Mol Syst Biol       Date:  2013-10-29       Impact factor: 11.429

10.  Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network.

Authors:  Viktória Lázár; István Nagy; Réka Spohn; Bálint Csörgő; Ádám Györkei; Ákos Nyerges; Balázs Horváth; Andrea Vörös; Róbert Busa-Fekete; Mónika Hrtyan; Balázs Bogos; Orsolya Méhi; Gergely Fekete; Balázs Szappanos; Balázs Kégl; Balázs Papp; Csaba Pál
Journal:  Nat Commun       Date:  2014-07-08       Impact factor: 14.919

View more
  80 in total

1.  Antibiotics: New recipe for targeting resistance.

Authors:  Balázs Papp; Viktória Lázár
Journal:  Nat Chem Biol       Date:  2016-10-18       Impact factor: 15.040

Review 2.  Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer.

Authors:  Simon Vyse; Annie Howitt; Paul H Huang
Journal:  J Mol Biol       Date:  2017-05-03       Impact factor: 5.469

Review 3.  Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution.

Authors:  Bram Van den Bergh; Toon Swings; Maarten Fauvart; Jan Michiels
Journal:  Microbiol Mol Biol Rev       Date:  2018-07-25       Impact factor: 11.056

4.  Endless Resistance. Endless Antibiotics?

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Medchemcomm       Date:  2015-11-03       Impact factor: 3.597

5.  Exploiting antimicrobial resistance: Better knowledge of resistance mechanisms can inform the search for and development of new antibiotics.

Authors:  Marc Ouellette; Arijit Bhattacharya
Journal:  EMBO Rep       Date:  2020-03-11       Impact factor: 8.807

Review 6.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

7.  Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae.

Authors:  Uri Obolski; José Lourenço; Craig Thompson; Robin Thompson; Andrea Gori; Sunetra Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-06       Impact factor: 11.205

8.  Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome In Vitro and in the Cystic Fibrosis Setting.

Authors:  Carla López-Causapé; Rosa Rubio; Gabriel Cabot; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

9.  A large-scale whole-genome comparison shows that experimental evolution in response to antibiotics predicts changes in naturally evolved clinical Pseudomonas aeruginosa.

Authors:  Samuel J T Wardell; Attika Rehman; Lois W Martin; Craig Winstanley; Wayne M Patrick; Iain L Lamont
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

Review 10.  Modeling Tumor Clonal Evolution for Drug Combinations Design.

Authors:  Boyang Zhao; Michael T Hemann; Douglas A Lauffenburger
Journal:  Trends Cancer       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.